Literature DB >> 27109162

Rheum palmatum L. Attenuates High Fat Diet-Induced Hepatosteatosis by Activating AMP-Activated Protein Kinase.

Mingxing Yang1, Xiumin Li1, Xin Zeng1, Zhimin Ou1, Mei Xue1, Dehong Gao1, Suhuan Liu1, Xuejun Li1,2, Shuyu Yang1,2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a common metabolic disorder characterized by the accumulation of excess fat in the liver. Rheum palmatumL. (RP) decoctions have been reported to ameliorate NAFLD. The aim of the present study was to investigate the effects and underlying mechanisms of RP in fatty liver disease induced by a high-fat diet (HFD) in rats. Low and high doses of aqueous RP extraction were orally administered to HFD-fed rats for six weeks. Body weight, tissue weight, glucose tolerance, insulin tolerance, hepatic morphology, and liver triglyceride (TG) content were assessed. The effects of RP on the expressions of lipogenic and lipolysis genes were measured by quantitative real-time PCR. The phosphorylation of AMP-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC) was determined by Western blotting. Treatment with low-dose RP significantly reduced liver weight, liver TG content, and improved glucose tolerance in HFD-fed rats. Consistently, RP attenuated excess fat accumulation and downregulated the expression of lipogenic genes in the liver. Further, an increased phosphorylation of AMPK and ACC was observed. These findings suggest that low-dose RP alleviates hepatosteatosis, at least in part, by stimulating AMPK activity.

Entities:  

Keywords:  ACC; AMPK; Nonalcoholic Fatty Liver Disease; Rheum palmatum L

Mesh:

Substances:

Year:  2016        PMID: 27109162     DOI: 10.1142/S0192415X16500300

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  8 in total

1.  [Effect of Hugan Qingzhi tablets on AMPK pathway activation and NF-κB-p65 protein expression in the liver of rats with nonalcoholic fatty liver disease].

Authors:  Xiao-Rui Yao; Fan Xia; Wai-Jiao Tang; Ben-Jie Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-01-20

Review 2.  Ethnobotanical Uses, Phytochemistry and Pharmacology of Different Rheum Species (Polygonaceae): A Review.

Authors:  Leila Mohtashami; Mohammad Sadegh Amiri; Zahra Ayati; Mahin Ramezani; Tannaz Jamialahmadi; Seyed Ahmad Emami; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  The Traditional Mongolian Medicine Qiqirigan-8 Effects on Lipid Metabolism and Inflammation in Obesity: Pharmacodynamic Evaluation and Relevant Metabolites.

Authors:  Xiaoqing Ding; Kexin Li; Dezhi Yang; Rui Yang; Dandan Yang; Haisheng Wang; Changshan Wang; Xilinqiqige Bao
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

4.  Chemical Components and Hepatoprotective Mechanism of Xwak Granule in Mice Treated with Acute Alcohol.

Authors:  Li Chen; Liu Liu; Rahima Abdulla; Xirali Tursun; Xuelei Xin; Haji Akber Aisa
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-28       Impact factor: 2.629

Review 5.  A Review on Rhubarb-Derived Substances as Modulators of Cardiovascular Risk Factors-A Special Emphasis on Anti-Obesity Action.

Authors:  Oleksandra Liudvytska; Joanna Kolodziejczyk-Czepas
Journal:  Nutrients       Date:  2022-05-13       Impact factor: 6.706

6.  Hepatoprotective Potency of Chrysophanol 8-O-Glucoside from Rheum palmatum L. against Hepatic Fibrosis via Regulation of the STAT3 Signaling Pathway.

Authors:  Yong Joo Park; Kwang Ho Lee; Mi Seon Jeon; Yong Hoon Lee; Yoon Joo Ko; Changhyun Pang; Bonglee Kim; Kyu Hyuck Chung; Ki Hyun Kim
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

Review 7.  Pharmacological effects of Chinese medicine modulating NLRP3 inflammasomes in fatty liver treatment.

Authors:  Tingting Liu; Guang Xu; Longxin Liang; Xiaohe Xiao; Yanling Zhao; Zhaofang Bai
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

Review 8.  Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine.

Authors:  Zhijia Zhou; Jinghao Zhang; Liping You; Tao Wang; Kaixia Wang; Lingtai Wang; Xiaoni Kong; Yueqiu Gao; Xuehua Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-20       Impact factor: 6.055

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.